All news

DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies

Alpha Vantage · ACCESS Newswire · · AI-summarised by FinFlash

DataMEDS AI announced an amended and restated non-binding letter of intent (LOI) to license and acquire intellectual property from several entities, including Datavault AI, Data Health Partners, EOS Technology Holdings, Scilex Holding Company, and HealthBridge Advisors. This transaction aims to consolidate IP enabling goal-driven prescription drug telehealth, medical drones, and healthcare blockchain technologies.

Read original source

MEDS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.